The Joint Preservation and Arthritis Center at NYU Langone Orthopedic Center is dedicated to advancing conservative treatment of joint-related problems and to providing personalized approaches to prolong the health of your joints.
U.S. News & World Report’s “Best Hospitals” ranks NYU Langone among the top 10 in the country for orthopedics, rheumatology, and rehabilitation.
Our goal is to reduce your symptoms, restore joint function, and delay the onset of degenerative arthritis in active people as well as in individuals who want to explore less-invasive alternatives to joint replacement.
As a patient at the Joint Preservation and Arthritis Center, your care is followed throughout the course of your condition. Careful monitoring of your progress is vital to pinpointing the right treatment for each person’s specific problem, and to determining when to consider the next step in the treatment process.
Whether you have injured your anterior cruciate ligament (ACL) and are considering ACL reconstruction, injured your cartilage and are contemplating cartilage replacement, or if you have a longstanding history of knee osteoarthritis and are considering total knee replacement, our physicians discuss surgical and nonsurgical options with you, and our recommendations may change as we follow you over time.
We offer a combination of diagnostic and treatment approaches, including:
Our experts include specialists from sports medicine, rheumatology, physical medicine and rehabilitation, radiology, adult orthopedic joint reconstruction, and physical therapy.
At the Joint Preservation and Arthritis Center, we perform clinical studies through NYU Langone’s Musculoskeletal Research Center. Through the Joint Preservation Partnership, we are customizing arthritis care for each patient. Our research program is led by Philip Band, PhD.
The Joint Preservation Partnership is a program designed to create a lifelong initiative for the management of arthritic conditions, and to maintain joint function in active individuals, regardless of their age. It unites experts within NYU Langone and beyond in studying, educating, treating, and promoting the preservation of joint function through individualized treatment for each patient.
To accomplish this, we are using advanced imaging techniques, biomarkers, and therapies intended to modify the disease process. The unifying goal of the Joint Preservation Partnership is to develop tools for identifying the most appropriate treatment for individual patients at each stage of arthritic disease. By improving arthritis treatment one patient at a time, the Joint Preservation Partnership aims to reduce the overall medical and socioeconomic burden of arthritis.
Currently, more than 100 ongoing clinical studies are evaluating new approaches to the treatment of musculoskeletal disease. Collaborations across specialties enable physical therapy techniques, medications, injectable agents, and new surgical techniques to be compared, and properly used to address each patient’s specific problem.
Biomarkers are being studied to determine an individual patient’s risk of disease progression, to identify the most appropriate treatment for each patient’s specific problem, and to monitor response to treatment. Useful biomarkers have been found in blood, from advanced MRI scans, and from synovial fluid—the fluid that lubricates and cushions joints.
Our researchers have also implemented internet-based systems to foster better communication between patients and clinicians, and as tools to study the comparative effectiveness of alternative treatment strategies.